Public health updates
22 October 2015
Faculty of Public Health joins the Academy of Medical Royal Colleges and seven leading organisations in calling on the Chancellor to reverse the decision to cut £200m from the local authority public health budget. To access the letter please click here.
13 October 2015
Extending the elderly- and risk-group programme of vaccination against seasonal influenza in England and Wales: a cost-effectiveness study by researchers at PHE and London School of Hygiene and Tropical Medicine.
1 October 2015
PHE's annual Tuberculosis (TB) in England report contained news on two fronts: another fall in the number of cases, and an update on the whole genome sequencing pilot.
23 September 2015
PHE has launched an investigation after the number of C difficile incidents in the English NHS rose last year for the first time since 2007. According to data in this month’s NHSE board papers, 2014-15 saw a 6 per cent increase in cases of C difficile compared to the previous year.
23 September 2015
18 September 2015
Part of PHE will migrate to new £350m facilities in Harlow to improve connectivity and collaboration with academia and the life sciences industry concentrated in that part of Essex. The new public health labs, to be based on a site currently owned by GlaxoSmithKline, will replace the “ageing facilities” at Porton Down in Wiltshire in a bid to enhance PHE’s involvement with research and innovation. The decision from the government comes following Public Health England’s submission of an Outline Business Case to the government in July 2014. A decision on the further PHE facilities in Colindale, London will be considered as part of the Spending Review.
15 September 2015
1 September 2015
A new programme to vaccinate all newborn babies against meningitis B has started in the UK - the first scheme of its kind in the world. The Men B vaccine will be given to babies at two, four and 12 months old as part of routine immunisations.
DH document NHS public health functions agreement 2015-16. Contains KPIs for immunisation and screening programmes.